Evaluation of the Safety and Efficacy of NBL-015 in Patients With Advanced Solid Tumors
Status:
Not yet recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
This trial is an open-label, multicenter, dose-escalation and cohort-expansion Phase I
clinical study in patients with advanced solid tumors. The aim of this study is to evaluate
the safety, tolerability, pharmacokinetics, and preliminary efficacy of NBL-015 in patients
with advanced solid tumors.